Search results
Results from the WOW.Com Content Network
Sun Pharmaceutical Industries Ltd. was established by Dilip Shanghvi in 1983 in Calcutta, West Bengal with five psychiatry products and a two-person marketing team. Today it is ranked number one in share of prescriptions with 12 classes of doctors in India and a market leader in Psychiatry, Neurology, Cardiology, Orthopaedics, Gastroenterology, Nephrology, Diabetology, Dermatology, Urology ...
Gujarat has become a hub for the pharmaceutical industry, with several established companies such as Torrent Pharmaceuticals, Zydus Lifesciences, Cadila Pharmaceuticals, Alembic Pharmaceuticals, Sun Pharma, Claris, Intas Pharmaceuticals, and Dishman Pharmaceuticals having operations in the state.
This is an accepted version of this page This is the latest accepted revision, reviewed on 23 January 2025. Indian Businessman Dilip Shanghvi Born (1955-10-01) 1 October 1955 (age 69) Amreli, Gujarat, India Alma mater Bhawanipur Education Society College, University of Calcutta Occupation(s) Founder and MD of Sun Pharmaceuticals Spouse Vibha Shanghvi Children 2 Dilip Shanghvi (born 1 October ...
This "formally initiates the litigation process under the Hatch-Waxman Act and triggers a 30-month stay of any potential FDA approval for Sun Pharma's ANDA," Mayne Pharma said in a statement.
In a further equity infusion, Dilip Shanghvi, the founder of Sun Pharmaceuticals, agreed to purchase a 23 percent stake in Suzlon for a sum of ₹ 1,800 crore (US$210 million). [16] The deal shrank Tanti's holding to 24 percent, but management control remained with the Tanti family.
In 2008, Japanese pharmaceutical company Daiichi Sankyo acquired a controlling share in Ranbaxy [2] and in 2014, Sun Pharma acquired 100% of Ranbaxy in an all-stock deal. The Sun Pharma acquisition brought all new management to Ranbaxy, which had been laden with controversy (see Controversies below). Sun is the world's fifth largest specialty ...
Torrent Group is an Indian multinational conglomerate, based in Ahmedabad. It was founded by Uttambhai Nathalal Mehta, [1] and now run by his sons, Sudhir and Samir Mehta. [2] The core businesses of the group are gas, pharmaceuticals and power. [3] As of September 2024, it has market capitalization of $25 billion.
Lincoln Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Ahmedabad, Gujarat, India. Lincoln Pharmaceuticals is engaged in the business of manufacturing, marketing and distribution of pharmaceutical products. [3] [4] Lincoln Pharmaceuticals is listed on National Stock Exchange of India (NSE) and Bombay ...